FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2072238796> ?p ?o ?g. }

• W2072238796 endingPage "288" @default.
• W2072238796 startingPage "282" @default.
• W2072238796 abstract "Surfactant therapy has become an effective standard therapy for infants with respiratory distress syndrome (RDS). The first dose may be given either as prophylaxis immediately after delivery, or as rescue after an infant has developed RDS. Second and subsequent doses are currently recommended by the manufacturers to be administered at minimal levels of respiratory support.This study compared the relative efficacy of administering second and subsequent doses of Infasurf surfactant at a low threshold (FIO(2) >30%, still requiring endotracheal intubation) versus a high threshold (FIO(2) >40%, mean airway pressure >7 cm H(2)O) of respiratory support.A total of 2484 neonates received a first dose of surfactant; 1267 reached conventional retreatment criteria and were randomized to be retreated according to low- or high-threshold criteria. They were then retreated at a minimum of 6-hour intervals each time they reached their assigned threshold until receiving a maximum of 4 total doses. Subjects were stratified by whether they received their first dose by prophylaxis or rescue and by whether their lung disease was considered complicated (evidence of perinatal compromise or sepsis) or uncomplicated.Among the patients randomized, 33% of prophylaxis and 23% of rescue subjects met criteria for the complicated stratum. Although infants allocated to the high-threshold strategy were receiving slightly more oxygen at 72 hours, there was no difference in the number receiving mechanical ventilation at 72 hours or in the secondary respiratory outcomes (requirement for supplemental oxygen or mechanical ventilation at 28 days, supplemental oxygen at 36 weeks' postconceptional age, inspired oxygen concentration >60% at any time). However, there was a significantly higher mortality for infants with complicated RDS who had received retreatment according to the high-threshold strategy.We conclude that equal efficacy can be realized by delaying surfactant retreatment of infants with uncomplicated RDS until they have reached a higher level of respiratory support than is the current standard. We speculate that this would result in a substantial cost-saving from less utilization of drug. Conversely, we believe that infants with complicated RDS should continue to be treated by the low-threshold retreatment strategy, which is currently recommended by the manufacturers of the commercially available surfactants." @default.
• W2072238796 created "2016-06-24" @default.
• W2072238796 creator A5024305679 @default.
• W2072238796 creator A5034867593 @default.
• W2072238796 creator A5037513659 @default.
• W2072238796 creator A5050090839 @default.
• W2072238796 creator A5053124558 @default.
• W2072238796 creator A5068483029 @default.
• W2072238796 creator A5070844318 @default.
• W2072238796 creator A5087254488 @default.
• W2072238796 creator A5091019722 @default.
• W2072238796 creator A5091179149 @default.
• W2072238796 date "2000-08-01" @default.
• W2072238796 modified "2023-10-18" @default.
• W2072238796 title "High-Versus Low-Threshold Surfactant Retreatment For Neonatal Respiratory Distress Syndrome" @default.
• W2072238796 cites W1518678424 @default.
• W2072238796 cites W1543428015 @default.
• W2072238796 cites W1971649325 @default.
• W2072238796 cites W1982688948 @default.
• W2072238796 cites W1992113101 @default.
• W2072238796 cites W2000480240 @default.
• W2072238796 cites W2001303504 @default.
• W2072238796 cites W2004774989 @default.
• W2072238796 cites W2005674803 @default.
• W2072238796 cites W2010198787 @default.
• W2072238796 cites W2010399227 @default.
• W2072238796 cites W2016184408 @default.
• W2072238796 cites W2033491834 @default.
• W2072238796 cites W2037966074 @default.
• W2072238796 cites W2046766740 @default.
• W2072238796 cites W2075132426 @default.
• W2072238796 cites W2078402449 @default.
• W2072238796 cites W2099253666 @default.
• W2072238796 cites W2103381031 @default.
• W2072238796 cites W2110854451 @default.
• W2072238796 cites W2162868360 @default.
• W2072238796 cites W2169502257 @default.
• W2072238796 cites W4233584275 @default.
• W2072238796 cites W4295094128 @default.
• W2072238796 doi "https://doi.org/10.1542/peds.106.2.282" @default.
• W2072238796 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10920152" @default.
• W2072238796 hasPublicationYear "2000" @default.
• W2072238796 type Work @default.
• W2072238796 sameAs 2072238796 @default.
• W2072238796 citedByCount "52" @default.
• W2072238796 countsByYear W20722387962012 @default.
• W2072238796 countsByYear W20722387962014 @default.
• W2072238796 countsByYear W20722387962016 @default.
• W2072238796 countsByYear W20722387962017 @default.
• W2072238796 countsByYear W20722387962018 @default.
• W2072238796 countsByYear W20722387962020 @default.
• W2072238796 countsByYear W20722387962021 @default.
• W2072238796 countsByYear W20722387962022 @default.
• W2072238796 crossrefType "journal-article" @default.
• W2072238796 hasAuthorship W2072238796A5024305679 @default.
• W2072238796 hasAuthorship W2072238796A5034867593 @default.
• W2072238796 hasAuthorship W2072238796A5037513659 @default.
• W2072238796 hasAuthorship W2072238796A5050090839 @default.
• W2072238796 hasAuthorship W2072238796A5053124558 @default.
• W2072238796 hasAuthorship W2072238796A5068483029 @default.
• W2072238796 hasAuthorship W2072238796A5070844318 @default.
• W2072238796 hasAuthorship W2072238796A5087254488 @default.
• W2072238796 hasAuthorship W2072238796A5091019722 @default.
• W2072238796 hasAuthorship W2072238796A5091179149 @default.
• W2072238796 hasConcept C126322002 @default.
• W2072238796 hasConcept C127413603 @default.
• W2072238796 hasConcept C141071460 @default.
• W2072238796 hasConcept C141983124 @default.
• W2072238796 hasConcept C168563851 @default.
• W2072238796 hasConcept C200457457 @default.
• W2072238796 hasConcept C2776006263 @default.
• W2072238796 hasConcept C2776596748 @default.
• W2072238796 hasConcept C2777080012 @default.
• W2072238796 hasConcept C2778376644 @default.
• W2072238796 hasConcept C2778716859 @default.
• W2072238796 hasConcept C2778721537 @default.
• W2072238796 hasConcept C2779234561 @default.
• W2072238796 hasConcept C2779547634 @default.
• W2072238796 hasConcept C2780395437 @default.
• W2072238796 hasConcept C42219234 @default.
• W2072238796 hasConcept C534529494 @default.
• W2072238796 hasConcept C54355233 @default.
• W2072238796 hasConcept C71924100 @default.
• W2072238796 hasConcept C78519656 @default.
• W2072238796 hasConcept C86803240 @default.
• W2072238796 hasConceptScore W2072238796C126322002 @default.
• W2072238796 hasConceptScore W2072238796C127413603 @default.
• W2072238796 hasConceptScore W2072238796C141071460 @default.
• W2072238796 hasConceptScore W2072238796C141983124 @default.
• W2072238796 hasConceptScore W2072238796C168563851 @default.
• W2072238796 hasConceptScore W2072238796C200457457 @default.
• W2072238796 hasConceptScore W2072238796C2776006263 @default.
• W2072238796 hasConceptScore W2072238796C2776596748 @default.
• W2072238796 hasConceptScore W2072238796C2777080012 @default.
• W2072238796 hasConceptScore W2072238796C2778376644 @default.
• W2072238796 hasConceptScore W2072238796C2778716859 @default.
• W2072238796 hasConceptScore W2072238796C2778721537 @default.
• W2072238796 hasConceptScore W2072238796C2779234561 @default.

• next